Skip to main content

Table 2 Age-stratified HPV distribution (15-year interval) in patients (n = 3134)

From: Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China’s top 3 hospital, 2009–2019

HPV Type/Age

< 20

20–34

35–49

50–64

65–80

Total

n

%

n

%

n

%

n

%

n

%

n

%

HPV6,11

0

0.00%

41

3.01%

36

1.82%

20

2.04%

7

4.64%

104

2.32%

HPV16

1

25.00%

367

26.91%

563

28.51%

254

25.92%

38

25.17%

1223

27.34%

HPV18

0

0.00%

78

5.72%

114

5.77%

54

5.51%

6

3.97%

252

5.63%

HPV21

0

0.00%

21

1.54%

23

1.16%

8

0.82%

0

0.00%

52

1.16%

HPV31

0

0.00%

48

3.52%

104

5.27%

33

3.37%

11

7.28%

196

4.38%

HPV33

0

0.00%

50

3.67%

89

4.51%

24

2.45%

6

3.97%

169

3.78%

HPV35

0

0.00%

31

2.27%

52

2.63%

27

2.76%

1

0.66%

111

2.48%

HPV39

2

50.00%

66

4.84%

79

4.00%

45

4.59%

6

3.97%

198

4.43%

HPV45

0

0.00%

11

0.81%

38

1.92%

12

1.22%

3

1.99%

64

1.43%

HPV51

0

0.00%

100

7.33%

110

5.57%

65

6.63%

8

5.30%

283

6.33%

HPV52

1

25.00%

146

10.70%

252

12.76%

119

12.14%

14

9.27%

532

11.89%

HPV56

0

0.00%

83

6.09%

89

4.51%

87

8.88%

14

9.27%

273

6.10%

HPV58

0

0.00%

171

12.54%

251

12.71%

119

12.14%

19

12.58%

560

12.52%

HPV59

0

0.00%

45

3.30%

56

2.84%

32

3.27%

8

5.30%

141

3.15%

HPV66

0

0.00%

38

2.79%

30

1.52%

41

4.18%

5

3.31%

114

2.55%

HPV67

0

0.00%

2

0.15%

23

1.16%

4

0.41%

2

1.32%

31

0.69%

HPV68

0

0.00%

50

3.67%

49

2.48%

22

2.24%

1

0.66%

122

2.73%

HPV82

0

0.00%

16

1.17%

17

0.86%

14

1.43%

2

1.32%

49

1.10%

Total

4

100.0%

1364

100.0%

1975

100%

980

100.0%

151

100.0%

4474

100.0%